Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 10KSB/A Other 10KSB/A
  2. PRE 14C Other PRE 14C
  3. 10KSB Other 10KSB
  4. 8-K/A Event Item 8
  5. 8-K Event Item 8
  6. 8-K/A Event Item 4
  7. 8-K/A Event Item 4
  8. SC 13D/A Stake Beneficial Ownership Report
  9. 8-K Event Item 4
  10. 10QSB Other 10QSB
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 10QSB/A Other 10QSB/A
  13. 10QSB Other 10QSB
  14. SC 13D/A Stake Beneficial Ownership Report
  15. PRER14A Other PRER14A
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 71 of 72 · 1,429 filings